文献速递青光眼角膜与眼表疾病

角膜生物力学与眼压看似控制良好患眼的视野进展

Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure.
PubMed 文献 · Ophthalmology · 2019-08-09

这项前瞻性队列研究纳入334例接受治疗青光眼患者的460只眼,平均随访4.3±0.8年,其中179只眼眼压控制良好(所有测量值<18 mmHg)。眼压控制良好的眼中42只(23.5%)出现视野进展;进展眼与稳定眼相比角膜滞后量(CH)更低(8.6±1.3 mmHg vs 9.4±1.6 mmHg,P=0.014)、中央角膜厚度(CCT)更薄(515.1±33.1 μm vs 531.1±42.4 μm,P=0.018);多因素分析中角膜指数每低1个标准差,进展风险升高68%(OR 1.68,95%CI 1.08-2.62,P=0.021)。

要点

  • 眼压控制良好(全部测量值<18 mmHg)的179只眼中,42只(23.5%)出现视野进展。
  • 进展眼较稳定眼CH更低(8.6±1.3 vs 9.4±1.6 mmHg,P=0.014)、CCT更薄(515.1±33.1 vs 531.1±42.4 μm,P=0.018)。
  • 角膜指数每低1个标准差,进展风险升高68%(OR 1.68,95%CI 1.08-2.62,P=0.021)。

核心结论

  • 约四分之一眼压控制良好的青光眼患眼可能随时间出现视野进展。
  • 薄角膜和低角膜滞后量是主要危险因素。

研究设计与样本

  • 前瞻性队列研究,纳入334例接受治疗青光眼患者的460只眼,平均随访4.3±0.8年。
  • 所有眼压测量值均小于18 mmHg者被归类为眼压控制良好(179只眼)。
  • 采用标准自动视野计(SAP)平均偏差(MD)随时间的最小二乘线性回归计算视野进展率,进展定义为MD斜率显著为负(α=0.05)。

主要发现

  • 眼压控制良好的179只眼中42只(23.5%)出现视野进展。
  • 进展眼与稳定眼基线MD无显著差异(-6.4±7.1 dB vs -6.0±6.2 dB,P=0.346)。
  • 进展眼与稳定眼平均眼压(11.7±2.0 mmHg vs 12.1±2.3 mmHg,P=0.405)、眼压波动(1.6±0.6 mmHg vs 1.6±0.5 mmHg,P=0.402)、峰值眼压(14.3±1.9 mmHg vs 14.6±2.1 mmHg,P=0.926)均无显著差异。
  • 进展眼较稳定眼CH显著更低(8.6±1.3 mmHg vs 9.4±1.6 mmHg,P=0.014)、CCT显著更薄(515.1±33.1 μm vs 531.1±42.4 μm,P=0.018)。
  • 多因素分析中,角膜指数(CH与CCT标准化值的总和)每低1个标准差,进展风险升高68%(OR 1.68,95%CI 1.08-2.62,P=0.021)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate the incidence and risk factors for glaucomatous visual field progression in eyes with well-controlled intraocular pressure (IOP). DESIGN: Prospective cohort. PARTICIPANTS: A total of 460 eyes of 334 patients with glaucoma under treatment. METHODS: Study subjects had a mean follow-up of 4.3±0.8 years. Patients were classified as well controlled if all IOP measurements were less than 18 mmHg. Rates of visual field progression were calculated using ordinary least-squares linear regression of standard automated perimetry (SAP) mean deviation (MD) values over time. Progression was defined as a significantly negative MD slope (alpha = 0.05). MAIN OUTCOME MEASURES: Rates of SAP MD change; mean and peak IOP, and IOP fluctuation; and corneal biomechanics: corneal hysteresis (CH), central corneal thickness (CCT), and corneal index. RESULTS: Of the 179 eyes with well-controlled IOP, 42 (23.5%) demonstrated visual field progression. There was no significant difference between progressing and stable patients in baseline MD (-6.4±7.1 decibels [dB] vs. -6.0±6.2 dB; P = 0.346), mean IOP (11.7±2.0 mmHg vs. 12.1±2.3 mmHg; P = 0.405), IOP fluctuation (1.6±0.6 mmHg vs. 1.6±0.5 mmHg; P = 0.402), or peak IOP (14.3±1.9 mmHg vs. 14.6±2.1 mmHg; P = 0.926). Progressing eyes had significantly lower CH (8.6±1.3 mmHg vs. 9.4±1.6 mmHg; P = 0.014) and thinner CCT (515.1±33.1 μm vs. 531.1±42.4 μm; P = 0.018, respectively) compared with stable eyes. In the multivariate analysis, a 1 standard deviation lower corneal index, a summation of normalized versions of CH and CCT, resulted in a 68% higher risk of progression (odds ratio, 1.68; 95% confidence interval, 1.08-2.62; P = 0.021). CONCLUSIONS: Approximately one-quarter of eyes with well-controlled IOP may show visual field progression over time. Thin cornea and low CH are main risk factors.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Susanna BN, Ogata NG, Jammal AA, et al. Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure. Ophthalmology. 2019. PMID: 31519385. doi:10.1016/j.ophtha.2019.07.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。